Articles related to ERECTILE DYSFUNCTION (ED)

A two-sample analysis of GWAS data identified genetically predicted associations between six commonly prescribed medications and increased erectile dysfunction risk, while aspirin did not reach statistical significance after SNP exclusions.

Neoadjuvant apalutamide plus abiraterone and ADT before radical prostatectomy was associated with improved 12-month potency recovery and lower positive surgical margin rates compared with surgery alone in a small phase 2 trial of men with high-risk localized prostate cancer.

Topical finasteride absorption through skin into bloodstream produces adverse events consistent with approved oral finasteride products, with 32 documented cases including erectile dysfunction, anxiety, and cognitive symptoms reported between 2019-2024.

Recent studies show cannabis use before intercourse helped 67% of women with orgasmic dysfunction achieve improved sexual satisfaction, highlighting its potential as a therapeutic option for female sexual health.

In the evolving landscape of erectile dysfunction treatment, alternative therapies offer hope beyond first-line medications. Current research and guidelines underscore the importance of comprehensive patient evaluation and the cautious integration of new therapeutic options.

Physicians must be vigilant of the impact that various medications can have on sexual function, including those less commonly associated with sexual side effects, to ensure holistic patient care and adherence to treatment.